PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
HIVE vs. CORZZ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


HIVECORZZ
Daily Std Dev88.51%131.63%
Max Drawdown-99.90%-59.61%
Current Drawdown-88.85%0.00%

Fundamentals


HIVECORZZ
Total Revenue (TTM)$126.11M$575.23M
Gross Profit (TTM)-$17.79M$171.18M
EBITDA (TTM)$20.81M$182.71M

Correlation

-0.50.00.51.00.5

The correlation between HIVE and CORZZ is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

HIVE vs. CORZZ - Performance Comparison

The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%100.00%200.00%300.00%400.00%500.00%AprilMayJuneJulyAugustSeptember
-6.85%
463.40%
HIVE
CORZZ

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HIVE vs. CORZZ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for HIVE Blockchain Technologies Ltd (HIVE) and Core Scientific Inc. Tranche 2 Warrants (CORZZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HIVE
Sharpe ratio
The chart of Sharpe ratio for HIVE, currently valued at -0.07, compared to the broader market-4.00-2.000.002.00-0.07
Sortino ratio
The chart of Sortino ratio for HIVE, currently valued at 0.56, compared to the broader market-6.00-4.00-2.000.002.004.000.56
Omega ratio
The chart of Omega ratio for HIVE, currently valued at 1.06, compared to the broader market0.501.001.502.001.06
Calmar ratio
The chart of Calmar ratio for HIVE, currently valued at -0.07, compared to the broader market0.001.002.003.004.005.00-0.07
Martin ratio
The chart of Martin ratio for HIVE, currently valued at -0.16, compared to the broader market-10.00-5.000.005.0010.0015.0020.00-0.16
CORZZ
Sharpe ratio
No data

HIVE vs. CORZZ - Sharpe Ratio Comparison


Chart placeholderNot enough data

Dividends

HIVE vs. CORZZ - Dividend Comparison

Neither HIVE nor CORZZ has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

HIVE vs. CORZZ - Drawdown Comparison

The maximum HIVE drawdown since its inception was -99.90%, which is greater than CORZZ's maximum drawdown of -59.61%. Use the drawdown chart below to compare losses from any high point for HIVE and CORZZ. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AprilMayJuneJulyAugustSeptember
-33.56%
0
HIVE
CORZZ

Volatility

HIVE vs. CORZZ - Volatility Comparison

HIVE Blockchain Technologies Ltd (HIVE) has a higher volatility of 26.22% compared to Core Scientific Inc. Tranche 2 Warrants (CORZZ) at 23.72%. This indicates that HIVE's price experiences larger fluctuations and is considered to be riskier than CORZZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%AprilMayJuneJulyAugustSeptember
26.22%
23.72%
HIVE
CORZZ

Financials

HIVE vs. CORZZ - Financials Comparison

This section allows you to compare key financial metrics between HIVE Blockchain Technologies Ltd and Core Scientific Inc. Tranche 2 Warrants. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items